Personalized Best: Toward Improving Care in Ulcerative Colitis

Nannaya Jampala; Animesh Jain; Hans H Herfarth; Millie D Long; Kimberly N Weaver; Edward L Barnes

doi:10.1007/s10620-021-07221-w

Personalized Best: Toward Improving Care in Ulcerative Colitis

Dig Dis Sci. 2021 Nov;66(11):3736-3739. doi: 10.1007/s10620-021-07221-w. Epub 2021 Aug 31.

Authors

Nannaya Jampala^{1

2}, Animesh Jain^{1

2}, Hans H Herfarth^{1

2}, Millie D Long^{1

2}, Kimberly N Weaver^{1

2}, Edward L Barnes^{3

4}

Affiliations

¹ Division of Gastroenterology and Hepatology, University of North Carolina At Chapel Hill, Campus Box #7080, 130 Mason Farm Road, Chapel Hill, NC, 27599-7080, USA.
² Multidisciplinary Center for Inflammatory Bowel Diseases, University of North Carolina At Chapel Hill, Chapel Hill, NC, USA.
³ Division of Gastroenterology and Hepatology, University of North Carolina At Chapel Hill, Campus Box #7080, 130 Mason Farm Road, Chapel Hill, NC, 27599-7080, USA. edward_barnes@med.unc.edu.
⁴ Multidisciplinary Center for Inflammatory Bowel Diseases, University of North Carolina At Chapel Hill, Chapel Hill, NC, USA. edward_barnes@med.unc.edu.

No abstract available

Keywords: Anti-tumor necrosis factor alpha; Inflammatory bowel disease; Optimization; Personalized medicine; Precision medicine; Ulcerative colitis.

Publication types

Case Reports
Research Support, N.I.H., Extramural

MeSH terms

Adalimumab / therapeutic use*
Anti-Inflammatory Agents / therapeutic use
Antibodies
Colitis, Ulcerative / genetics
Colitis, Ulcerative / therapy*
Female
Humans
Mesalamine / therapeutic use*
Prednisone / therapeutic use*
Young Adult

Substances

Anti-Inflammatory Agents
Antibodies
Mesalamine
Adalimumab
Prednisone

Grants and funding

K23 DK127157/DK/NIDDK NIH HHS/United States